ChemDiv and Berlex Announce Lead Compound Discovery Collaboration
14-Mar-2006
Under the terms of the collaboration, ChemDiv will apply its integrated synthetic and medicinal chemistry capabilities and collaborate with Berlex's scientists in the search for new disease therapies. Financial terms were not disclosed.
Organizations
Berlex
ChemDiv
Bayer Schering Pharma
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.